From our findings, we also showed that nanoliposome-loaded C6-ceremide (LipC6) can increase tumor cell apoptosis and show a synergistic effect with the adoptive transfer of tumor antigen-specific (TAS) CD8 T cells with subsequent immunization [148]. The gene discussed is CD8A; the disease is neoplasm.